Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Cytokinetics
CYTK
$11B
| $21.7M | ﹤0.01% |
539,110
+399,993
| +288% | +$18.4M |
|
|
AXON
1677
Axon Enterprise
AXON
$49.4B
| $21.7M | ﹤0.01% |
41,183
+4,308
| +12% | +$2.52M |
|
1678
CALL
KeyCorp
KEY
$23.6B
| $21.7M | ﹤0.01% |
1,354,600
-562,200
| -29% | -$9.54M |
|
1679
Indivior Pharmaceuticals
INDV
$4.23B
| $21.7M | ﹤0.01% |
2,271,942
+2,050,248
| +925% | +$21.6M |
|
1680
Workday
WDAY
$47.1B
| $21.6M | ﹤0.01% |
92,672
-21,546
| -19% | -$5.5M |
|
1681
PUT
BioMarin Pharmaceuticals
BMRN
$12.7B
| $21.6M | ﹤0.01% |
305,000
-495,300
| -62% | -$33.3M |
|
|
AZEK
1682
DELISTED
The AZEK Co
AZEK
| $21.5M | ﹤0.01% |
440,266
+213,821
| +94% | +$10.1M |
|
|
WBA
1683
DELISTED
Walgreens Boots Alliance
WBA
| $21.5M | ﹤0.01% |
1,926,854
-1,387,566
| -42% | -$15.1M |
|
|
CTRA
1684
CALL
DELISTED
Coterra Energy
CTRA
| $21.5M | ﹤0.01% |
744,200
-338,000
| -31% | -$9.43M |
|
|
RDFN
1685
CALL
DELISTED
Redfin
RDFN
| $21.5M | ﹤0.01% |
2,333,300
+574,100
| +33% | +$4.91M |
|
|
P
1686
CALL
Everpure Inc
P
$36.2B
| $21.4M | ﹤0.01% |
484,500
-245,400
| -34% | -$14.8M |
|
1687
News Corp Class A
NWSA
$16.6B
| $21.4M | ﹤0.01% |
787,291
-15,416
| -2% | -$431K |
|
1688
PUT
KB Home
KBH
$3.44B
| $21.4M | ﹤0.01% |
368,600
-912,200
| -71% | -$58.1M |
|
1689
CALL
NuScale Power
SMR
$3.8B
| $21.4M | ﹤0.01% |
1,512,600
+249,900
| +20% | +$5.05M |
|
1690
CALL
Peabody Energy
BTU
$3.33B
| $21.4M | ﹤0.01% |
1,580,500
-567,900
| -26% | -$9.14M |
|
1691
CALL
Citizens Financial Group
CFG
$29.7B
| $21.4M | ﹤0.01% |
521,500
+13,400
| +3% | +$598K |
|
1692
PUT
Tradeweb Markets
TW
$22.7B
| $21.4M | ﹤0.01% |
143,900
-500
| -0.3% | -$66.5K |
|
1693
CALL
Baker Hughes
BKR
$61.5B
| $21.3M | ﹤0.01% |
485,000
-326,800
| -40% | -$14.6M |
|
1694
PUT
Sanofi
SNY
$109B
| $21.3M | ﹤0.01% |
384,300
+40,500
| +12% | +$2.19M |
|
1695
CALL
Exelixis
EXEL
$13.9B
| $21.3M | ﹤0.01% |
575,700
+122,700
| +27% | +$4.37M |
|
1696
Zoetis
ZTS
$32B
| $21.2M | ﹤0.01% |
128,913
-102,232
| -44% | -$17M |
|
1697
Baxter International
BAX
$13.7B
| $21.2M | ﹤0.01% |
619,612
-99,258
| -14% | -$3.25M |
|
1698
CALL
Vodafone
VOD
$36.8B
| $21.2M | ﹤0.01% |
2,263,400
+1,539,800
| +213% | +$13.5M |
|
|
COOP
1699
CALL
DELISTED
Mr. Cooper
COOP
| $21.2M | ﹤0.01% |
177,200
+64,100
| +57% | +$6.69M |
|
1700
CALL
Barclays
BCS
$91.1B
| $21.2M | ﹤0.01% |
1,379,100
+137,400
| +11% | +$2.06M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.